Detalhe da pesquisa
1.
SAPPHIRE: phase III study of sitravatinib plus nivolumab versus docetaxel in advanced nonsquamous non-small-cell lung cancer.
Ann Oncol;
35(1): 66-76, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37866811
2.
Assessing and improving the outcomes of nonpoint source water quality trading policies in urban areas: A case study in Virginia.
J Environ Manage;
345: 118724, 2023 Nov 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37542805
3.
Early switch from run-in treatment with vemurafenib plus cobimetinib to atezolizumab after 3 months leads to rapid loss of tumour control in patients with advanced BRAFV600-positive melanoma: The ImmunoCobiVem phase 2 randomised trial.
Eur J Cancer;
190: 112941, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37482012
4.
Associations of tissue tumor mutational burden and mutational status with clinical outcomes in KEYNOTE-042: pembrolizumab versus chemotherapy for advanced PD-L1-positive NSCLC.
Ann Oncol;
34(4): 377-388, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36709038
5.
ESMO expert consensus statements on the management of EGFR mutant non-small-cell lung cancer.
Ann Oncol;
33(5): 466-487, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35176458
6.
Effectiveness, safety and utilization of vismodegib in locally advanced basal cell carcinoma under real-world conditions in Germany - The non-interventional study NIELS.
J Eur Acad Dermatol Venereol;
35(8): 1678-1685, 2021 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-33931910
7.
The value of interventional radiology in clinical trial teams: experience from the BATTLE lung cancer trials.
Clin Radiol;
76(2): 155.e25-155.e34, 2021 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-33268083
8.
Chemoradiotherapy efficacy is predicted by intra-tumour CD8+/FoxP3+ double positive T cell density in locally advanced N2 non-small-cell lung carcinoma.
Eur J Cancer;
135: 221-229, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32610210
9.
GNAQ and GNA11 mutant nonuveal melanoma: a subtype distinct from both cutaneous and uveal melanoma.
Br J Dermatol;
183(5): 928-939, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32064597
10.
Elevated baseline serum PD-1 or PD-L1 predicts poor outcome of PD-1 inhibition therapy in metastatic melanoma.
Ann Oncol;
31(1): 144-152, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31912789
11.
EGFR mutation subtypes and response to immune checkpoint blockade treatment in non-small-cell lung cancer.
Ann Oncol;
30(8): 1311-1320, 2019 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31086949
12.
Use of archival versus newly collected tumor samples for assessing PD-L1 expression and overall survival: an updated analysis of KEYNOTE-010 trial.
Ann Oncol;
30(2): 281-289, 2019 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30657853
13.
A prospective observational safety study of patients with BRAFV 600 -mutated unresectable or metastatic melanoma treated with vemurafenib (Zelboraf Safety Study).
Br J Dermatol;
180(5): 1254-1255, 2019 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-30488430
14.
CD19-positive antibody-secreting cells provide immune memory.
Blood Adv;
2(22): 3163-3176, 2018 11 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-30478153
15.
A dormant TIL phenotype defines non-small cell lung carcinomas sensitive to immune checkpoint blockers.
Nat Commun;
9(1): 3196, 2018 08 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-30097571
16.
Whole-exome sequencing and immune profiling of early-stage lung adenocarcinoma with fully annotated clinical follow-up.
Ann Oncol;
29(4): 1072, 2018 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29688333
17.
Intermediate-dose cytarabine plus mitoxantrone versus standard-dose cytarabine plus daunorubicin for acute myeloid leukemia in elderly patients.
Ann Oncol;
29(4): 973-978, 2018 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29390048
18.
Expression of the CTLA-4 ligand CD86 on plasmacytoid dendritic cells (pDC) predicts risk of disease recurrence after treatment discontinuation in CML.
Leukemia;
32(4): 1054, 2018 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-29381150
19.
Development of the BELANA questionnaire for the analysis of economic burdens of food allergy and intolerance.
Allergol Select;
2(1): 17-28, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-31826030
20.
Evolution of NPM1-negative therapy-related myelodysplastic syndromes following curative treatment of NPM1-mutant AML.
Leukemia;
31(10): 2247-2251, 2017 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-28690314